You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Over 480 Covid-19 patients given plasma therapy at two Delhi govt hospitals

Over 480 Covid-19 patients have been administered convalescent plasma therapy at the Lok Nayak Jai Prakash Narayan Hospital and Rajiv Gandhi Super Speciality Hospital over the last few months

Delhi | Coronavirus

Press Trust of India  |  New Delhi 

Coronavirus, covid, tests

Over 480 COVID-19 patients have been administered convalescent plasma therapy at the government-run Lok Nayak Jai Prakash Narayan Hospital and Rajiv Gandhi Super Speciality Hospital over the last few months, officials said on Tuesday.

LNJP Hospital and RGSSH are dedicated facilities.

Plasma therapy was started at the LNJP Hospital, the largest under the government, in June. Later, Delhi's second plasma bank was set up at the hospital in July.

The national capital's first plasma bank was inaugurated at the state-run Institute of Liver and Biliary Science (ILBS) on July 2 by Chief Minister Arvind Kejriwal.

The LNJP Hospital has 2,000 beds, of which 432 were occupied as on Monday. Of these, 258 patients are in the ICU, said Suresh Kumar, medical director of the hospital.

"Till a couple of days ago, about 286 patients had received plasma therapy. Males outnumber females, and mostly people aged above 60 need it," he told PTI.

Kumar said only serious patients whose condition is deteriorating are administered this therapy.

Initially, people's response to calls for donating convalescent plasma for COVID-19 patients in was "lukewarm". Doctors had attributed it to apprehensions about associated health risks and the tendency to put off donation for any future need of family members in case they get infected.

However, with increased awareness and the situation getting somewhat better in terms of daily cases, the number of donors has risen, according to officials.

"Each person can donate 250-500 ml of plasma. We give the first dosage of 250 ml to the recipient, and if needed, the second dosage of 250 ml after 24 hours," Kumar said.

At RGSSH in east Delhi, over 200 patients have been administered the plasma therapy till date, its Medical Director B L Sherwal told PTI.

"We have been combating COVID-19 for a long time now, and there have been several learnings too. The plasma therapy is a trial and it is administered with the assumption that it will help. Also, old and young both may need it depending on a patient's condition," he said.

RGSSH has 650 beds out of which 119 are occupied. Ninety-one patients are in the ICU and five of them on invasive ventilatory support, Sherwal said.

"We have also created a place to cryogenically store donor plasma which we get from the ILBS," he said.

For donors, people who have recently recovered from COVID-19 and developed antibodies, there are some strict criteria. Counselling and screening is done for them before the actual donation process begins. The process for each donor is completed within two to two-and-a-half hours.

A donor's antibodies are transferred to the recipient through plasma.

People in the age group of 18-60 who have fully recovered from COVID-19 and show no symptoms for 14 days can go for donation subject to strict guidelines for eligible donors.

Someone weighing less than 50 kg, women who have ever been pregnant, cancer survivors, and those with kidney, heart, lung or liver diseases are not eligible to donate plasma.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, October 06 2020. 19:31 IST